A post-hoc exploratory analysis of the SURPASS-3 study used MRI to assess thigh muscle composition in 246 insulin-naive patients with T2D and obesity, comparing tirzepatide to insulin degludec over 52 weeks [71]. The gene discussed is INS; the disease is type 2 diabetes mellitus.